Erlotinib Completed Phase 1 Trials for Adult Primary Hepatocellular Carcinoma / Advanced Adult Primary Liver Cancer / Localized Unresectable Adult Primary Liver Cancer / Recurrent Adult Primary Liver Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00047346Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction